$IMLFF InMed is a pre-clinical stage biopharmaceutical company that specializes in developing novel therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems. InMed’s proprietary bioinformatics assessment tool, biosynthesis manufacturing process and drug development pipeline are the fundamental value drivers of the Company.

For more information, visit www.inmedpharma.com